Breast Carcinoma: Updates in Molecular Profiling 2018.

Area of Science:

• Oncology
• Genomics
• Molecular Biology

Background:

• Molecular subtyping of breast carcinomas has identified distinct estrogen-positive and estrogen-negative tumor subtypes.
• Understanding genetic alterations is crucial for identifying novel therapeutic targets in breast cancer.

Purpose of the Study:

• To leverage genomic and epigenomic data for a comprehensive understanding of breast cancer carcinogenesis.
• To identify targetable mutations and improve risk stratification for patients with in situ and invasive carcinoma.

Main Methods:

• Utilized genomic and epigenomic data collected by the Cancer Genome Analysis Network.
• Analyzed carcinogenesis and pathway interactions within breast tumor subtypes.

Main Results:

• Identified key differences between estrogen-positive and estrogen-negative breast cancer subtypes.
• Provided comprehensive data on molecular alterations driving breast cancer progression.

Conclusions:

• Molecular subtyping and comprehensive genomic analysis are vital for advancing breast cancer treatment.
• This approach enhances the identification of therapeutic targets and improves patient risk stratification.